Agilent Technologies, Inc. (A) Financials

A Assets vs Liabilities

DateAssetsLiabilities
July 31, 2026 14.0 billion 6.6 billion
April 30, 2026 13.1 billion 5.9 billion
Jan. 31, 2026 12.8 billion 5.9 billion
Oct. 31, 2025 12.7 billion 6.0 billion

A Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
July 31, 2026 439.0 million 32.0 million
April 30, 2026 370.0 million 32.0 million
Jan. 31, 2026 175.0 million 41.0 million
Oct. 31, 2025 452.0 million 26.0 million

A Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
July 31, 2026 362.0 million
April 30, 2026 339.0 million
Jan. 31, 2026 305.0 million
Oct. 31, 2025 434.0 million

A Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
July 31, 2026 1.8 billion 3.6 billion -
April 30, 2026 1.8 billion 3.1 billion -
Jan. 31, 2026 1.8 billion 3.1 billion -
Oct. 31, 2025 1.8 billion 3.1 billion -

A Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
July 31, 2026 283.0 million
April 30, 2026 284.0 million
Jan. 31, 2026 284.0 million
Oct. 31, 2025 284.0 million

A Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
July 31, 2026 80.0 million 123.0 million 475.0 million -
April 30, 2026 93.0 million 126.0 million 465.0 million -
Jan. 31, 2026 93.0 million 117.0 million 476.0 million -
Oct. 31, 2025 93.0 million 119.0 million 428.0 million -

A Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
July 31, 2026 1.9 billion 836.0 million
April 30, 2026 1.8 billion 826.0 million
Jan. 31, 2026 1.8 billion 852.0 million
Oct. 31, 2025 1.9 billion 897.0 million

A Revenue by Segment

Graph available only for paid members. Upgrade to see it.

A

List: Contenders

Price: $173.07

52 week price:
108.35
177.76

Dividend Yield: 0.59%

5-year range yield:
0.51%
0.89%

Forward Dividend Yield: 0.59%

Payout Ratio: 19.63%

Payout Ratio Range:
-15.00%
398.26%

Dividend Per Share: 1.02 USD

Earnings Per Share: 5.08 USD

P/E Ratio: 30.23

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 1.7 million

Ebitda: 304.0 million

Market Capitalization: 48.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 15

DGR3: 5.71%

DGR5: 6.63%

DGR10: 9.56%

Links: